CN101843830B - Chinese medicament for treating pulmonary heart diseases - Google Patents

Chinese medicament for treating pulmonary heart diseases Download PDF

Info

Publication number
CN101843830B
CN101843830B CN2009102421682A CN200910242168A CN101843830B CN 101843830 B CN101843830 B CN 101843830B CN 2009102421682 A CN2009102421682 A CN 2009102421682A CN 200910242168 A CN200910242168 A CN 200910242168A CN 101843830 B CN101843830 B CN 101843830B
Authority
CN
China
Prior art keywords
parts
radix
chinese
chinese medicine
chinese medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2009102421682A
Other languages
Chinese (zh)
Other versions
CN101843830A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Huilong Vientiane Garden
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102421682A priority Critical patent/CN101843830B/en
Publication of CN101843830A publication Critical patent/CN101843830A/en
Application granted granted Critical
Publication of CN101843830B publication Critical patent/CN101843830B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicament for treating pulmonary heart diseases and belongs to the field of Chinese medicaments for treating respiratory diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: baical skullcap root, lucid ganoderma, perilla fruit, Chinese angelica, radix pseudo-ginseng, common coltsfoot flower, lily, campanumaea pilosula and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, reducing sputum and relieving cough, and activating blood, dissolving stasis and calming heart, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of pulmonary heart disease
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
The existing Chinese medicine aspect that is used for the treatment of pulmonary heart disease, the deficiency that has two aspects: the one, therapeutic effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of patients with cor pulmonale are subsisted in uncomfortable in chest, cardiopalmus, dyspnea for a long time, edema of lower limbs, cough is breathed hard, and can not alleviate for many years, and patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of pulmonary heart disease, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of pulmonary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Scutellariae 4---30 parts of 30 portions of Ganodermas 2---12 parts of Fructus Perillaes 4---
Radix Angelicae Sinensis 4---30 parts of 30 portions of Radix Notoginseng 3---20 portions of Flos Farfaraees 4---
20 parts of Bulbus Liliies 4---30 parts of Radix Codonopsis 3---
The Chinese medicine of this treatment pulmonary heart disease is made by following method:
(1) by above-mentioned weight ratio, Radix Scutellariae, Fructus Perillae, Radix Angelicae Sinensis, Flos Farfarae, Bulbus Lilii, Radix Codonopsis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Codonopsis benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, tonification the five internal organs; The Radix Scutellariae removing heat from the lung and dissipating phlegm; The yin nourishing of Bulbus Lilii tonifying the lung; Fructus Perillae, Flos Farfarae resolving phlegm and relieving asthma cough-relieving; Be aided with Radix Angelicae Sinensis, Radix Notoginseng blood-supplementing blood-nourishing, the blood circulation promoting and blood stasis dispelling mind calming.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and preventing phlegm from forming and stopping coughing, the merit of blood circulation promoting and blood stasis dispelling mind calming, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Scutellariae 70 kairine sesames 30 gram Fructus Perillaes 70 grams
Radix Angelicae Sinensis 70 gram Radix Notoginseng 40 gram Flos Farfaraees 70 grams
Bulbus Lilii 70 gram Radix Codonopsis 40 grams
Weight in accordance with regulations, with conventional water extraction process Radix Scutellariae, Fructus Perillae, Radix Angelicae Sinensis, Flos Farfarae, Bulbus Lilii, Radix Codonopsis are extracted, make extractum fine powder 117 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 667 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Scutellariae 170 kairine sesames 60 gram Fructus Perillaes 170 grams
Radix Angelicae Sinensis 170 gram Radix Notoginseng 90 gram Flos Farfaraees 170 grams
Bulbus Lilii 170 gram Radix Codonopsis 90 grams
By above-mentioned same method, make 1542 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Scutellariae 300 kairine sesames 120 gram Fructus Perillaes 300 grams
Radix Angelicae Sinensis 300 gram Radix Notoginseng 200 gram Flos Farfaraees 300 grams
Bulbus Lilii 300 gram Radix Codonopsis 200 grams
By above-mentioned same method, make 2964 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
8 parts of 4 parts of Fructus Perillaes of 8 portions of Ganodermas of Radix Scutellariae
8 parts of 6 portions of Flos Farfaraees of 8 portions of Radix Notoginseng of Radix Angelicae Sinensis
6 parts of 8 parts of Radix Codonopsis of Bulbus Lilii
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 8 parts of Fructus Perillaes of 20 portions of Ganodermas of Radix Scutellariae
20 parts of 15 portions of Flos Farfaraees of 20 portions of Radix Notoginseng of Radix Angelicae Sinensis
15 parts of 20 parts of Radix Codonopsis of Bulbus Lilii
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science pulmonary heart disease, through 7 routine clinical observations.Selecting the tcm diagnosis pulmonary heart disease is standard: have a delicate constitution, and limb adynamia, feeling of oppression and pain in the chest, cough is breathed hard, dyspnea, edema of lower limbs.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 2 examples do not have other serious disease, and the age is 49 years old-79 years old, 62.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, symptoms such as feeling of oppression and pain in the chest, dyspnea are obviously alleviated.
2, effective: body constitution strengthens, and symptoms such as feeling of oppression and pain in the chest, dyspnea are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. a Chinese medicine for the treatment of pulmonary heart disease adopts the raw material of Chinese medicine preparation, it is characterized in that it is to make with the component of following weight ratio:
4-30 parts of 2-12 parts of Fructus Perillaes of 4-30 parts of Ganodermas of Radix Scutellariae
4-30 parts of 3-20 parts of Flos Farfaraees of 4-30 parts of Radix Notoginseng of Radix Angelicae Sinensis
3-20 parts of 4-30 parts of Radix Codonopsis of Bulbus Lilii
The Chinese medicine of this treatment pulmonary heart disease is made by following method:
(1) by above-mentioned weight ratio, Radix Scutellariae, Fructus Perillae, Radix Angelicae Sinensis, Flos Farfarae, Bulbus Lilii, Radix Codonopsis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine electuary, granule, powder, capsule, watered pill, tablet.
CN2009102421682A 2009-12-09 2009-12-09 Chinese medicament for treating pulmonary heart diseases Active CN101843830B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102421682A CN101843830B (en) 2009-12-09 2009-12-09 Chinese medicament for treating pulmonary heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102421682A CN101843830B (en) 2009-12-09 2009-12-09 Chinese medicament for treating pulmonary heart diseases

Publications (2)

Publication Number Publication Date
CN101843830A CN101843830A (en) 2010-09-29
CN101843830B true CN101843830B (en) 2011-07-27

Family

ID=42768768

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102421682A Active CN101843830B (en) 2009-12-09 2009-12-09 Chinese medicament for treating pulmonary heart diseases

Country Status (1)

Country Link
CN (1) CN101843830B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406618A (en) * 2001-09-06 2003-04-02 卢庆来 Chinese herbal medicine preparation for treating bronchitis and laryngopharyngitis
CN101167949A (en) * 2007-09-24 2008-04-30 罗永忠 Traditional Chinese medicine for treating cough

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406618A (en) * 2001-09-06 2003-04-02 卢庆来 Chinese herbal medicine preparation for treating bronchitis and laryngopharyngitis
CN101167949A (en) * 2007-09-24 2008-04-30 罗永忠 Traditional Chinese medicine for treating cough

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李春华等.炙甘草汤治疗慢性肺心病缓解期36例.《吉林中医药》.2004,第25卷(第1期),第20页. *

Also Published As

Publication number Publication date
CN101843830A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843660B (en) Chinese medicament for treating tachycardia
CN101850017B (en) Chinese medicament for treating asthma
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101884762B (en) Traditional Chinese medicine for treating emphysema
CN101897847B (en) Traditional Chinese medicine for curing asthma
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101850018A (en) Chinese medicament for treating cervical spondylosis
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101850083B (en) Chinese medicament for treating asthma
CN101850079B (en) Chinese medicament for treating asthma
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101850014B (en) Chinese medicament for treating asthma
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101843832B (en) Chinese medicament for treating coronary disease
CN101850034B (en) Chinese medicament for treating angina
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843720B (en) Chinese medicament for treating angina
CN101843719A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20131108

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226299 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131108

Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side)

Patentee after: Qidong Huilong Vientiane Garden

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.